Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery.

Circ Cardiovasc Interv

From the Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK (J.I.); Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK (C.S.K., M.A.M.); Department of Cardiology, Royal Stoke Hospital, University Hospital North Midlands NHS Trust, UK (C.S.K., M.G., M.A.M.); Farr Institute, University of Manchester, Manchester, UK (E.K., M.A.M.); Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK (M.A.d.B.); Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK (P.F.L.); and Department of Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK (M.G., A.Z.).

Published: April 2016

AI Article Synopsis

  • A study analyzed the outcomes of patients with ST-segment-elevation myocardial infarction (STEMI) who had undergone previous coronary artery bypass grafting (CABG) and were treated with primary percutaneous coronary intervention (PPCI).
  • Among 79,295 patients tracked from 2007 to 2012, 3.4% had prior CABG, with differing mortality rates observed at 30 days for those treated via native arteries or grafts compared to those without CABG.
  • Despite higher initial mortality rates in CABG patients, when factors were accounted for, prior CABG did not significantly increase mortality risk, indicating it reflects other high-risk traits rather than adding to the risk itself.

Article Abstract

Background: There are limited data on outcomes of patients with previous coronary artery bypass grafting (CABG) presenting with ST-segment-elevation myocardial infarction (STEMI) and undergoing primary percutaneous coronary intervention (PPCI). We report outcomes in patients with STEMI undergoing PPCI with or without previous CABG surgery in a large real-world, all-comer population.

Methods And Results: Clinical, demographic, procedural, and outcomes data were collected for all patients undergoing PPCI in England and Wales from January 2007 to December 2012. All-cause mortality at 30 days and 1 year were evaluated in the whole and a propensity-matched cohort. Of 79 295 patients with STEMI studied, 2658 (3.4%) patients had prior CABG, of whom 44% (n=1168) underwent PPCI to native vessels and 56% (n=1490) to bypass grafts. There were significant differences in the demographic, clinical, and procedural characteristics of these groups. Patients with prior CABG (with primary PCI to native artery or graft) had higher mortality at 30 days (6.2% with PPCI to native artery, 6.1% with PPCI to bypass graft) than patients with no prior CABG (4.5%; P<0.001). However, after risk factor adjustments, there was no significant difference in outcomes. There were also no significant differences in 30-day mortality, in-hospital major adverse cardiovascular events, in-hospital stroke, and in-hospital bleeding in the propensity-matched population.

Conclusions: A prior history of CABG in patients presenting with STEMI and undergoing PPCI does not independently confer additional risk of mortality, although it is a marker of other high-risk features.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.003151DOI Listing

Publication Analysis

Top Keywords

patients prior
12
prior cabg
12
primary percutaneous
8
percutaneous coronary
8
coronary intervention
8
patients
8
patients previous
8
previous coronary
8
coronary artery
8
artery bypass
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!